Analysis of mutations of MDR3 exons 9 and 23 in infants with parenteral nutrition-associated cholestasis

作者：Yang, Xiu-Fang; Liu, Guo-Sheng^*; Li, Min-Xu

来源：Experimental and Therapeutic Medicine, 2015, 10(6): 2361-2365.

DOI：10.3892/etm.2015.2800

• parenteral nutrition associated-cholestasis
• multidrug resistance 3 gene
• mutation
• clinical features

The aim of this study was to investigate mutations of multidrug resistance 3 (MDR3) exons 9 and 23 in infants with parenteral nutrition-associated cholestasis (PNAC). A total of 41 infants with PNAC were enrolled in the study. Genomic DNA was extracted from the peripheral venous blood leukocytes of each patient and MDR3 exons 9 and 23 were amplified by polymerase chain reaction. One patient was identified who carried a frameshift mutation in MDR3 exon 23 (C.2793) that was caused by the insertion of a single adenine residue, while mutations were not found in MDR3 exon 23 in the other 40 patients. The clinical features of the patient with the MDR3 exon 23 frameshift mutation included high serum gamma-glutamyl transferase levels, the absence of biliary dilatation and deformity in magnetic resonance cholangiopancreatography, and abnormal electrical capacitance tomography imaging of the liver. No mutations in MDR3 exon 9 were identified in any of the patients. All 41 PNAC patients recovered following oral ursodeoxycholic acid treatment. The C.2793 frameshift mutation in MDR3 exon 23 is potentially associated with the development of PNAC in infants.

• 出版日期2015-12
• 单位中山市人民医院; 中山大学; 暨南大学